CN1304036C - 降压消脂保健组合物 - Google Patents
降压消脂保健组合物 Download PDFInfo
- Publication number
- CN1304036C CN1304036C CNB031344135A CN03134413A CN1304036C CN 1304036 C CN1304036 C CN 1304036C CN B031344135 A CNB031344135 A CN B031344135A CN 03134413 A CN03134413 A CN 03134413A CN 1304036 C CN1304036 C CN 1304036C
- Authority
- CN
- China
- Prior art keywords
- extract powder
- blood pressure
- blood
- powder
- powdered extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 21
- 230000036772 blood pressure Effects 0.000 title claims abstract description 16
- 239000008280 blood Substances 0.000 title abstract description 13
- 210000004369 blood Anatomy 0.000 title abstract description 13
- 239000000284 extract Substances 0.000 claims abstract description 32
- 239000000843 powder Substances 0.000 claims description 45
- 230000036541 health Effects 0.000 claims description 13
- 241000628997 Flos Species 0.000 claims description 9
- 239000009636 Huang Qi Substances 0.000 claims description 9
- 235000020717 hawthorn extract Nutrition 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 9
- 210000000582 semen Anatomy 0.000 claims description 9
- 206010020772 Hypertension Diseases 0.000 abstract description 14
- 201000005577 familial hyperlipidemia Diseases 0.000 abstract description 6
- 230000006870 function Effects 0.000 abstract description 3
- 230000001105 regulatory effect Effects 0.000 abstract description 2
- 238000005728 strengthening Methods 0.000 abstract description 2
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 1
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 1
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 230000036737 immune function Effects 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 description 9
- 230000017531 blood circulation Effects 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 239000002220 antihypertensive agent Substances 0.000 description 2
- 229940127088 antihypertensive drug Drugs 0.000 description 2
- 230000036770 blood supply Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 208000021760 high fever Diseases 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 230000029865 regulation of blood pressure Effects 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 241000668709 Dipterocarpus costatus Species 0.000 description 1
- 208000007530 Essential hypertension Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010035148 Plague Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 231100000682 maximum tolerated dose Toxicity 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明涉及一种降压消脂保健组合物,该组合物是由油菜花粉、决明子浸膏粉、山楂浸膏粉、黄芪浸膏粉、红花浸膏粉、山药浸膏粉制成,本发明具有调节血压,降低血脂,延缓高血压进展以及合并高脂血症,增强机体免疫力功能的作用,可达到预防和辅助治疗高血压症以及合并高脂血症的目的。
Description
技术领域
本发明涉及一种降压消脂的保健组合物。
背景技术
高血压——人类的无声杀手,是危害人类健康及生命的现代流行病之一,是当今世界上发病率最高的疾病之一,它是引起脑卒中、冠心病、肾功能不全的重要危险因素。高血压病又称原发性高血压,其形成原因到目前为止,还不十分明了。但目前一致公认:是由各种因素的影响,使正常血压的调节功能失调而形成的。大量流行病调查资料表明:大脑皮层功能紊乱,高级神经中枢功能失调,在发病中占主导地位,体液、内分泌、肾脏参与发病过程。
抗高血压药物是治疗高血压病的重要治疗措施,高血压的病因并非单一因素所致,因此治疗也应是综合性治疗,是高血压患者最理想的治疗方法。过分地依赖降压药,尤其是西药降压药,这是临床中存在的一种错误倾向。任何降压药物都有程度不等的副作用,药物治疗并不是理想的治疗方法。整体治疗取得的效果更好,而且可减少西药降压药的剂量和副作用。由于历史条件的限制,古代中医文献中没有高血压病的病名记载。据统计,高血压病患者以眩晕为主要症状者约占70%,头痛、心悸、失眠约占40%-50%,因此可归属于中医学的眩晕、头痛的范畴。中医辩证分型直接与病因病机相关,基本病因病机为本虚标实,病位以肝肾心脾为重点,其中又以肝肾为主,认为高血压由于七情所伤、饮食失节、内伤四脏所引起的阴阳平衡失调。中医辨证施治以“虚则补之”,或滋补肝、肾,壮水制火,或补肾填精、益髓充脑,或补益肾气、强筋壮骨,或温补肾阳、化气行水:理气活血,或益气通脉,以助心之行血,改善心、脑、肾等靶器官血液供应,解除因血压升高导致心脑肾等重要器官血流供求平衡的矛盾。或清心安神,或涤痰开窍以使神清志明,恢复功能。同时还应注意配合平肝益肾、健脾化痰。对于因湿痰所致,治以温药和之,佐以健脾和胃,对于痰热作祟,治以化痰清热,佐以熄风泻火:活血化瘀,调畅血行,活血通络祛除瘀滞,使血行气畅,改善重要靶器熄风泻火:活血化瘀,调畅血行,活血通络祛除瘀滞,使血行气畅,改善重要靶器官血液供应失衡,达到血压下降。
发明内容
本发明的目的是为了提供一种具有调节血压,降低血脂,延缓高血压进展以及合并高脂血症,增强机体免疫力功能作用,达到预防和辅助治疗高血压症以及合并高脂血症的降压消脂保健组合物。
本发明的目的可通过如下措施来实现:
一种降压消脂保健组合物的原料重量百分含量为:
油菜花粉10-80%、决明子浸膏粉1-40%、山楂浸膏粉1-40%、黄芪浸膏粉1-30%、红花浸膏粉1-30%、山药浸膏粉1-30%。
本发明相比现有技术具有如下优点:
1、本发明的配伍中含有本发明的最佳实施方式含有丰富的蛋白质、氨基酸、维生素和矿物质元素等易被人体吸收利用的营养物质成分,其中总黄酮、总蒽醌和多糖为主要功效成分;因而本发明具有良好的调节血压、降低血脂,预防高血压以及合并高脂血症的功能作用。
2、本发明经急性毒性实验未测出小鼠LD50,小鼠最大耐受量大于20.0g/kg体重,属无毒级物质。
3、本发明适用于高血压症、高脂血症及并发症患者服用。
具体实施方式
实施例一:
一种降压消脂保健组合物是由下述重量百分含量的原料制成:
油菜花粉79% 决明子浸膏粉5% 山楂浸膏粉5%
黄芪浸膏粉4% 红花浸膏粉4% 山药浸膏粉3%。
实施例二:
一种降压消脂保健组合物是由下述重量百分含量的原料制成:
油菜花粉46% 决明子浸膏粉39% 山楂浸膏粉12%
黄芪浸膏粉1% 红花浸膏粉1% 山药浸膏粉1%。
实施例三:
一种降压消脂保健组合物是由下述重量百分含量的原料制成:
油菜花粉20% 决明子浸膏粉20% 山楂浸膏粉39%
黄芪浸膏粉7% 红花浸膏粉7% 山药浸膏粉7%。
实施例四:
一种降压消脂保健组合物是由下述重量百分含量的原料制成:
油菜花粉60% 决明子浸膏粉10% 山楂浸膏粉2%
黄芪浸膏粉20% 红花浸膏粉4% 山药浸膏粉4%。
实施例五:
一种降压消脂保健组合物是由下述重量百分含量的原料制成:
油菜花粉11% 决明子浸膏粉2% 山楂浸膏粉25%
黄芪浸膏粉20% 红花浸膏粉29% 山药浸膏粉13%。
实施例六:
一种降压消脂保健组合物是由下述重量百分含量的原料制成:
油菜花粉15% 决明子浸膏粉8% 山楂浸膏粉8%
黄芪浸膏粉29% 红花浸膏粉20% 山药浸膏粉20%。
Claims (2)
1、一种降压消脂保健组合物,其特征在于该组合物的原料重量百分含量为:
油菜花粉10-80% 决明子浸膏粉1-40% 山楂浸膏粉1-40%
黄芪浸膏粉1-30% 红花浸膏粉1-30% 山药浸膏粉1-30%。
2、如权利要求1所述的降压消脂保健组合物,其特征在于该组合物的原料重量百分含量为:
油菜花粉20-60% 决明子浸膏粉5-30% 山楂浸膏粉5-30%
黄芪浸膏粉5-20% 红花浸膏粉5-20% 山药浸膏粉5-20%。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031344135A CN1304036C (zh) | 2003-06-24 | 2003-06-24 | 降压消脂保健组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031344135A CN1304036C (zh) | 2003-06-24 | 2003-06-24 | 降压消脂保健组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1565542A CN1565542A (zh) | 2005-01-19 |
CN1304036C true CN1304036C (zh) | 2007-03-14 |
Family
ID=34470187
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB031344135A Expired - Fee Related CN1304036C (zh) | 2003-06-24 | 2003-06-24 | 降压消脂保健组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1304036C (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1940949B (zh) * | 2005-09-29 | 2013-06-19 | 霍夫曼-拉罗奇有限公司 | 确定动态聚合酶链反应扩增曲线中的周期阈值的方法和设备 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101940317B (zh) * | 2010-03-25 | 2012-07-25 | 无锡市天赐康生物科技有限公司 | 一种提高人体免疫力的保健食品及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1297763A (zh) * | 1999-11-30 | 2001-06-06 | 任宣茂 | 天麻降压茶 |
-
2003
- 2003-06-24 CN CNB031344135A patent/CN1304036C/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1297763A (zh) * | 1999-11-30 | 2001-06-06 | 任宣茂 | 天麻降压茶 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1940949B (zh) * | 2005-09-29 | 2013-06-19 | 霍夫曼-拉罗奇有限公司 | 确定动态聚合酶链反应扩增曲线中的周期阈值的方法和设备 |
Also Published As
Publication number | Publication date |
---|---|
CN1565542A (zh) | 2005-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1169541C (zh) | 治疗类风湿性关节炎的药物 | |
CN1253201C (zh) | 一种治疗偏头痛的药物 | |
CN1899582A (zh) | 一种治疗慢性胃炎的药及其制备方法 | |
CN103566346B (zh) | 一种治疗中老年腹胀的药物及制备方法 | |
CN1286518C (zh) | 一种治疗胃病的中药组合物 | |
CN1304036C (zh) | 降压消脂保健组合物 | |
CN1692939A (zh) | 一种治疗乙型肝炎中药药丸的制作方法 | |
CN1382473A (zh) | 治疗精神性疾病的药物 | |
CN1232693A (zh) | 防治高血压、高血脂保健饮料 | |
CN1141138C (zh) | 一种治疗冠心病的药物组合物 | |
CN1416872A (zh) | 祛风、散寒、除湿保健酒 | |
CN1136899C (zh) | 一种治疗乳腺增生的药物 | |
CN1045892C (zh) | 防治冠心病心绞痛的中药制剂 | |
CN1245197C (zh) | 治疗冠心病、病毒性心肌炎的中药制剂 | |
CN1117872A (zh) | 保健药酒 | |
CN1425456A (zh) | 一种调节人体平衡机能的滋补酒 | |
CN104971214A (zh) | 一种具有抗疲劳作用的中药组合物 | |
CN1723950A (zh) | 一种治疗高脂血症及其并发症的中药药物 | |
CN1228065C (zh) | 一种治疗慢性肾功能衰竭的药物 | |
CN1555873A (zh) | 治疗高血压疾病的中草药药物 | |
CN1269517C (zh) | 抗艾滋病毒口服液 | |
CN101912547B (zh) | 一种治疗眩晕的药物及其制备方法 | |
CN102114174A (zh) | 一种治疗急性胆囊炎的中药 | |
CN1069533C (zh) | 一种预防脑血栓的药物 | |
CN1168483C (zh) | 一种治疗心脏病的药物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070314 |